COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.

clinical-trials-Brazil

CRO in Brazil – Opportunities and Challenges in Brazil.

Brazil is a large country with over 200 million inhabitants, making it the largest population in Latin America.

covid-19-vaccine-Latam

COVID-19 Trials in Latin America – Shot only 47% Effective.

The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected. Now, the proposed delivery of 225 million doses to the EU is at risk.

Cohortias - The CRO of Latin America

Local CRO in Mexico – Cohortias the CRO of Latin America.

Cohortias is redefining Clinical Research in Latin America.

Contract Research Organization in Argentina

Contract Research Organization in Argentina – New regulations.

The Ministry of Health in Argentina issued a new regulation that significantly reduces the timelines for the approval of clinical trials.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.